Clinical Hold
FDA order that halts a clinical trial or dosing, typically after safety concerns, until the sponsor resolves the issue.
As defined in Biotech’s Chief Evangelist
Where it comes up · 1
- Biotech’s Chief Evangelist2 claims
Most important claims · 2 of 2Search all claims for “Clinical Hold” →
- Amicus's first Pompe small molecule, after four years of research and promising animal and healthy volunteer data, caused the first two adult patients to get weaker, and the company had to stop dosing and seek a clinical hold because the drug's half-life in diseased human muscle differed from healthy volunteers.Biotech’s Chief Evangelist
- When a public biotech had to disclose a clinical hold after patients worsened, the stock fell about 50 percent in one day, which forced the CEO to deal with investor fallout alongside patient safety.Biotech’s Chief Evangelist